Jump to section
To revolutionise life sciences by harnessing the potential of quantum computing to solve currently inaccessible problems. Algorithmiq envisions a world in which new drugs can be discovered and invented quickly, efficiently and cost-effectively, leading to affordable and precise medical treatments.
The life sciences sector is primed for quantum computing, with the technology poised to greatly reduce the time and cost required to bring a drug to market. Without instructions, however, quantum computers can’t achieve these savings alone. Algorithmiq, a Finnish quantum-computing software developer, exists to provide these instructions, allowing quantum computers to bring their full power to bear on chemistry simulations.
While Algorithmiq isn’t unique in developing quantum software, its hybrid approach is. Its drug discovery platform, Aurora, combines noise-resilient quantum computing with classical algorithms, allowing for the solving of problems that are completely impossible to achieve with classical hardware and software alone. The company’s recent fundraise will be used to form collaborations within the global pharmaceutical industry and to further develop the platform, with an aim of developing a proof of concept that will outperform the most powerful classical computers in drug discovery before the end of 2023.
Steph
Company Specialist at Welcome to the Jungle
Jun 2023
$14.5m
SERIES A
Feb 2022
$4m
SEED
Sabrina Maniscalco
(CEO)Professor of Quantum Information, Computing and Logic at the University of Helsinki. Has been working on Quantum Technology for over 20 years, focussing on noise in quantum devices, complex quantum systems and quantum simulations.
Matteo Rossi
(CTO)Holds a PhD in Quantum Physics from the University of Milan and did postdoctoral research at University of Turku and Aalto University (Finland).
Boris Sokolov
(Senior Researcher)Degree in Electronics and a PhD from the University of Turku on the topic of open quantum systems, special relativity and complex systems.
Holds a PhD from the Univ. of Barcelona and did postdoctoral research at the Univ. of Turku and the Univ. of Helsinki. Co-founded Algorithmiq in 2020 and has worked as CSO since then.